|
|
PUBLICATIONS :- 2023 - Azzaz F, Chahinian H, Yahi N, Fantini J, Di Scala C.
AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer's Disease Therapy.
Int J Mol Sci, 24 : 1760 - 2022 - Azzaz F, Yahi N, Di Scala C, Chahinian H, Fantini J.
Ganglioside binding domains in proteins: Physiological and pathological mechanisms
Advances in Protein Chemistry and Structural Biology, 128 : 289-324 - 2022 - Di Scala C, Amstrong N, Chahinian H, Chabrière E, Fantini J, Yahi N.
AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer's and Parkinson's Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery
Int J Mol Sci, 23 : 13383 - 2021 - Fantini J, Chahinian H, Yahi N.
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
Biochemical and Biophysical Research Communication, 538 : 132-136 - 2021 - Fantini J, Yahi N, Azzaz F, Chahinian H.
Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks
Journal of Infection, 83 : 197-206 - 2021 - Yahi N, Di Scala C, Chahinian H, Fantini J.
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease
Glycoconjugate Journal - 2021 - Yahi N, Chahinian H, Fantini J.
Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
The Journal of infection, J Infect. 2021 Aug 9. pii: S0163-4453(21)00392-3. doi: 10.1016/j.jinf.2021.08.010. - 2021 - Assou EL-Battari, Léa Rodriguez, Chahinian H, Olivier Delézay, Fantini J, Yahi N, Coralie Di Scala.
Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells
- 2020 - Fantini J, Di Scala C, Chahinian H, Yahi N.
Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
International Journal of Antimicrobial Agents, 55 : 105960 - 2020 - Fantini J, Chahinian H, Yahi N.
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal
International Journal Antimicrobial Agents, 56 : 106020 - 2020 - Fantini J, Chahinian H, Yahi N.
Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?
Protein Science, 29 : 1748-1759 - 2020 - Fantini J, Chahinian H, Yahi N.
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
Biochemical and Biophysical Research Communications, doi: 10.1016/j.bbrc.2020.10.015. - 2018 - Coralie Di Scala, Fantini J, Yahi N, Francisco J. Barrantes, Chahinian H.
Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter
Biomolecules, 8
|
|
